98%
921
2 minutes
20
Ménétrier's disease (MD) is a rare hypertrophic gastropathy marked by enlarged gastric folds, excessive mucus secretion, and protein-losing enteropathy. We present the case of a 25-year-old man initially hospitalized with severe chronic anemia, which revealed a rare and challenging form of MD. The patient reported persistent epigastric pain, vomiting, and recurrent hematemesis. Biological workup showed profound hypoalbuminemia (20 g/L) and microcytic anemia (Hb 5.8 g/dL, ferritin 3 ng/mL). Abdominal CT and upper endoscopy revealed massive polypoid thickening of the gastric fundus with cerebral-like folds and friable polypoid lesions. Histology confirmed foveolar hyperplasia with glandular atrophy, consistent with MD, in the absence of infection. Despite supportive care, the patient experienced recurrent gastrointestinal bleeding and transfusion-dependent anemia, ultimately requiring total gastrectomy. Surgery led to a significant improvement in symptoms and nutritional status. The case report emphasizes the diagnostic complexity and challenges of managing MD, particularly in patients with severe presentations. The successful outcome following total gastrectomy underscores the importance of considering surgical options in selected cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375279 | PMC |
http://dx.doi.org/10.7759/cureus.88724 | DOI Listing |
Korean J Clin Oncol
August 2025
Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting toxicity associated with oxaliplatin-based chemotherapy in gastric cancer patients. Recent studies suggest that high-dose intravenous selenium may exert neuroprotective effects in patients receiving platinum-based chemotherapy.
Methods: This pilot study analyzed patients with stage III gastric adenocarcinoma who underwent gastrectomy between January and December 2024.
Obes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
University of Michigan, Ann Arbor, MI, USA.
Background: Hypocalcemia is common after cervical procedures. Patients who have undergone Roux-en-Y gastric bypass (RYGB) experience increased risk for post-thyroidectomy hypocalcemia. This association has not been elucidated for nonbariatric operations that bypass the duodenum.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Ultrasound, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Gastrosplenic fistula is a rare complication, most often secondary to gastric or splenic lymphoma. Severe gastrosplenic fistula can cause life-threatening upper gastrointestinal bleeding, making early diagnosis and intervention critical for a favorable prognosis. Currently, surgical intervention remains the primary treatment; however, outcomes are often suboptimal.
View Article and Find Full Text PDFJ Gastrointest Surg
September 2025
Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, United States. Electronic address:
Background: The development of cholelithiasis and its subsequent complications are a known risk after vertical sleeve gastrectomy (VSG) due to rapid weight loss. Although controversial, concomitant cholecystectomy (CCY) at the time of bariatric surgery has been proposed, with multiple studies investigating simultaneous CCY with Roux-en-Y gastric bypass. Despite VSG being the most commonly performed bariatric surgery in the United States (US) and globally, few studies have investigated the simultaneous VSG and CCY.
View Article and Find Full Text PDF